Determining the value contribution of emicizumab (Hemlibra...

Determining the value contribution of emicizumab (Hemlibra ® ) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Álvarez-Román, Maria Teresa, Cuervo-Arango, Ignacio, Pérez-Santamarina, Rafael, Poveda, José Luís, Romero, José Antonio, Santamaría, Amparo, Trillo-Mata, José Luís, Tort, Marina, Badia, Xavier
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2019
Language:
english
Journal:
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
DOI:
10.1177/2284240319880534
Date:
January, 2019
File:
PDF, 487 KB
english, 2019
Conversion to is in progress
Conversion to is failed